tirzepatide for diabetes Blood sugar drug also leads to substantial weight loss in patients, Eli Lilly says NICE recommends Lilly's tirzepatide for

VN: Conceptualization, Formal analysis, Investigation, Methodology, Resources, Supervision, Validation, Writing original draft, Writing review & editing

Cardiovascular Health: This compound is studied for its potential to improve heart function and energy metabolism, making it a candidate for treatments in heart disease

However, there is a growing amount of research that suggests these drugs may provide several other health benefits

More recently, tofersen (QALSODY ), an antisense oligonucleotide targeting mutant SOD1 , has shown potential in reducing NfL levels and slowing functional decline, though concerns remain regarding inflammatory side effects and the failure of initial phase III trials [7678]

Ozempic hair loss was not listed in diabetes trials, but shedding is reported when calorie intake falls quickly